Association between viral hepatitis infection and Parkinson's disease: A population-based prospective study
- PMID: 32558154
- DOI: 10.1111/jvh.13346
Association between viral hepatitis infection and Parkinson's disease: A population-based prospective study
Abstract
The association between hepatitis virus infection and Parkinson's disease remains controversial. To determine whether hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are associated with an increased risk of Parkinson's disease in Korean aged ≥40 years, we completed a population-based prospective study including patients without infections and those with HBV, HCV and HBV/HCV infections from 2005 to 2015. We used the International Classification of Diseases 10th Revision to identify Parkinson's disease (G20) and chronic hepatitis C virus (B18.2) and chronic hepatitis B virus infections (B18.0 or B18.1). To identify Parkinson's disease risk, competing risk analysis adjusted for age, sex, comorbidities and death was performed. Overall, 1 010 317 patients (358 052, noninfection; 488 990, hepatitis B; 144 459 hepatitis C; and 18 680 hepatitis B/C) were included. The incidence density of Parkinson's disease per 10 000 person-years was highest in the hepatitis C group (8.0), followed by the hepatitis B/C (6.8) and hepatitis B (5.0) groups. Hypertension, ischaemic heart disease, epilepsy, stroke and depressive disorder increased the hazard of Parkinson's disease in all groups. The adjusted hazard ratios were 1.25 (95% confidence interval: 1.17-1.35), 1.39 (95% confidence interval: 1.27-1.52) and 1.46 (95% confidence interval: 1.14-1.85) in the HBV, HCV, and HBV/HCV groups, respectively. Our findings suggest that adult patient of 40 years and older with HBV and HCV infections should be monitored for signs of Parkinson's disease so that early intervention and accurate treatment can be provided for minimizing the development and consequences of Parkinson's disease.
Keywords: Parkinson's disease; Viral hepatitis B; Viral hepatitis C; competing risk; prospective studies.
© 2020 John Wiley & Sons Ltd.
Similar articles
-
Risk of Parkinson's disease in hepatitis B and C populations: a systematic review and meta-analysis.J Neural Transm (Vienna). 2024 Jun;131(6):609-616. doi: 10.1007/s00702-023-02705-7. Epub 2023 Oct 29. J Neural Transm (Vienna). 2024. PMID: 37899363 Review.
-
Risk of diabetes in viral hepatitis B or C patients compared to that in noninfected individuals in Korea, 2002-2013: A population-based cohort study.J Viral Hepat. 2018 Mar;25(3):272-280. doi: 10.1111/jvh.12815. Epub 2017 Dec 8. J Viral Hepat. 2018. PMID: 29080254
-
A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.Int J Epidemiol. 1998 Aug;27(4):574-8. doi: 10.1093/ije/27.4.574. Int J Epidemiol. 1998. PMID: 9758109
-
Hepatitis B and C virus infection as a risk factor for Parkinson's disease in Israel-A nationwide cohort study.J Neurol Sci. 2019 Mar 15;398:138-141. doi: 10.1016/j.jns.2019.01.012. Epub 2019 Jan 11. J Neurol Sci. 2019. PMID: 30710864
-
Coinfection of Schistosoma Species with Hepatitis B or Hepatitis C Viruses.Adv Parasitol. 2016;91:111-231. doi: 10.1016/bs.apar.2015.12.003. Epub 2016 Feb 5. Adv Parasitol. 2016. PMID: 27015949 Review.
Cited by
-
SARS-CoV-2 and Parkinson's Disease: A Review of Where We Are Now.Biomedicines. 2023 Sep 13;11(9):2524. doi: 10.3390/biomedicines11092524. Biomedicines. 2023. PMID: 37760965 Free PMC article. Review.
-
Decreased Risk of Parkinson's Disease After Rheumatoid Arthritis Diagnosis: A Nested Case-Control Study with Matched Cases and Controls.J Parkinsons Dis. 2021;11(2):821-832. doi: 10.3233/JPD-202418. J Parkinsons Dis. 2021. PMID: 33682730 Free PMC article.
-
Understanding Immune Responses to Viruses-Do Underlying Th1/Th2 Cell Biases Predict Outcome?Viruses. 2022 Jul 8;14(7):1493. doi: 10.3390/v14071493. Viruses. 2022. PMID: 35891472 Free PMC article. Review.
-
Risk of Parkinson's disease in hepatitis B and C populations: a systematic review and meta-analysis.J Neural Transm (Vienna). 2024 Jun;131(6):609-616. doi: 10.1007/s00702-023-02705-7. Epub 2023 Oct 29. J Neural Transm (Vienna). 2024. PMID: 37899363 Review.
-
A functional role for alpha-synuclein in neuroimmune responses.J Neuroimmunol. 2023 Mar 15;376:578047. doi: 10.1016/j.jneuroim.2023.578047. Epub 2023 Feb 8. J Neuroimmunol. 2023. PMID: 36791583 Free PMC article. Review.
References
REFERENCES
-
- Foundation P.Understanding Parkionson's: Statistics. Understanding Parkionson's 2018. http://parkinson.org/Understanding-Parkinsons/Causes-and-Statistics/Stat.... Accessed February 14, 2017.
-
- Tysnes OB, Storstein A. Epidemiology of Parkinson's disease. J Neural Transm (Vienna). 2017;124(8):901-905.
-
- Wooten GF. Are men at greater risk for Parkinson's disease than women? J Neurol Neurosurg Psychiatry. 2004;75(4):637-639.
-
- Moisan F, Kab S, Mohamed F, et al. Parkinson disease male-to-female ratios increase with age: French nationwide study and meta-analysis. J Neurol Neurosurg Psychiatry. 2016;87(9):952-957.
-
- Pakpoor J, Noyce A, Goldacre R, et al. Viral hepatitis and Parkinson disease A national record-linkage study. Am Acad Neurol. 2017;29:210-212.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical